GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fresh Tracks Therapeutics Inc (OTCPK:FRTX) » Definitions » Shiller PE Ratio

Fresh Tracks Therapeutics (Fresh Tracks Therapeutics) Shiller PE Ratio : (As of Apr. 27, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Fresh Tracks Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Fresh Tracks Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Fresh Tracks Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresh Tracks Therapeutics Shiller PE Ratio Chart

Fresh Tracks Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Fresh Tracks Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Fresh Tracks Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Fresh Tracks Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresh Tracks Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fresh Tracks Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Fresh Tracks Therapeutics's Shiller PE Ratio falls into.



Fresh Tracks Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Fresh Tracks Therapeutics's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Fresh Tracks Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.2/129.4194*129.4194
=-0.200

Current CPI (Dec. 2023) = 129.4194.

Fresh Tracks Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -126.000 99.695 -163.568
201406 -157.500 100.560 -202.701
201409 -157.500 100.428 -202.967
201412 -157.500 99.070 -205.750
201503 -126.000 99.621 -163.689
201506 -94.500 100.684 -121.471
201509 -9.450 100.392 -12.182
201512 -81.900 99.792 -106.215
201603 -81.900 100.470 -105.498
201606 -44.100 101.688 -56.126
201609 -75.600 101.861 -96.054
201612 -78.750 101.863 -100.054
201703 -78.750 102.862 -99.082
201706 -94.500 103.349 -118.338
201709 -85.050 104.136 -105.700
201712 -66.150 104.011 -82.309
201803 -91.350 105.290 -112.285
201806 -69.300 106.317 -84.359
201809 -22.050 106.507 -26.794
201812 -53.550 105.998 -65.383
201903 111.600 107.251 134.668
201906 -34.650 108.070 -41.495
201909 -74.250 108.329 -88.705
201912 -62.100 108.420 -74.128
202003 -20.250 108.902 -24.065
202006 -19.350 108.767 -23.024
202009 -6.750 109.815 -7.955
202012 -6.750 109.897 -7.949
202103 -6.750 111.754 -7.817
202106 -7.290 114.631 -8.230
202109 -7.150 115.734 -7.995
202112 -2.700 117.630 -2.971
202203 -3.550 121.301 -3.788
202206 -0.430 125.017 -0.445
202209 -2.070 125.227 -2.139
202212 -1.500 125.222 -1.550
202303 -1.140 127.348 -1.159
202306 -0.390 128.729 -0.392
202309 0.320 129.860 0.319
202312 -0.200 129.419 -0.200

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Fresh Tracks Therapeutics  (OTCPK:FRTX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Fresh Tracks Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Fresh Tracks Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresh Tracks Therapeutics (Fresh Tracks Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
5777 Central Avenue, Suite 102, Boulder, CO, USA, 80301
Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.
Executives
Monica E. Luchi officer: Chief Medical Officer 430 EAST 29TH STREET, SUITE 940, NEW YORK NY 10016
Reginald L Hardy director, officer: CHAIRMAN OF THE BOARD
David R. Mcavoy officer: General Counsel and CCO C/O ENDOCYTE, INC., 3000 KENT AVENUE, SUITE A1-100, WEST LAFAYETTE IN 47906
Deepak Chadha officer: Chief Research & Dev. Officer 5777 CENTRAL AVENUE, SUITE 102, BOULDER CO 80301
Vijay B Samant director 10390 PACIFIC CENTER COURT, SAN DIEGO CA 92121
Jose Breton officer: Chief Accounting Officer 5777 CENTRAL AVENUE, SUITE 102, BOULDER CO 80301
Robert Busard Brown director, officer: Chief Executive Officer 5777 CENTRAL AVENUE, SUITE 102, BOULDER CO 80301
Andrew D Sklawer officer: COO and Secretary 5777 CENTRAL AVENUE, SUITE 102, BOULDER CO 80301
Dennison T Veru director C/O PALIDADE CAPITAL, ONE BRIDGE PLAZA NORTH #695, FORT LEE NJ 07024
Marchio Albert N Ii officer: Chief Financial Officer
Gary A Lyons director 12790 EL CAMINO REAL, C/O NEUROCRINE BIOSCIENCES, SAN DIEGO CA 92130
Sanjeev Ahuja officer: Chief Medical Officer 121 3RD STREET NW, CARMEL IN 46032
Adam Scott Levy officer: Chief Business Officer C/O MIRAGEN THERAPEUTICS, INC., 6200 LOOKOUT ROAD, #100, BOULDER CO 80301
William Ju director 5777 CENTRAL AVENUE, SUITE 102, BOULDER CO 80301
R Michael Carruthers officer: Chief Financial Officer 3122 STERLING CIRCLE, SUITE 200, BOULDER CO 80301